Literature DB >> 24006291

Increase of histaminergic tuberomammillary neurons in narcolepsy.

Philipp O Valko1, Yury V Gavrilov, Mihoko Yamamoto, Hasini Reddy, Johannes Haybaeck, Emmanuel Mignot, Christian R Baumann, Thomas E Scammell.   

Abstract

OBJECTIVE: Narcolepsy is caused by loss of the hypothalamic neurons producing the orexin/hypocretin neuropeptides. One key target of the orexin system is the histaminergic neurons of the tuberomammillary nucleus (TMN), an essential wake-promoting system. As cerebrospinal fluid histamine levels may be low in patients with narcolepsy, we examined histaminergic neurons in patients with narcolepsy and in 2 mouse models of narcolepsy.
METHODS: We counted the number of hypothalamic neurons producing orexin, melanin-concentrating hormone, and histamine in 7 narcolepsy patients and 12 control subjects using stereological techniques. We identified histaminergic neurons using immunostaining for histidine decarboxylase. We also examined these systems in 6 wild-type mice, 6 orexin/ataxin-3 transgenic mice, and 5 orexin ligand knockout mice.
RESULTS: Compared to controls, narcolepsy patients had 94% more histaminergic TMN neurons (233,572 ± 49,476 vs 120,455 ± 10,665, p < 0.001). This increase was higher in 5 narcolepsy patients with >90% orexin neuron loss than in 2 patients with ≤75% orexin neuron loss (252,279 ± 46,264 vs 186,804 ± 1,256, p = 0.03). Similarly, the number of histaminergic TMN neurons was increased 53% in orexin ligand knockout mice compared to wild-type mice, whereas orexin/ataxin-3 transgenic mice showed an intermediate 28% increase.
INTERPRETATION: This surprising increase in histaminergic neurons in narcolepsy may be a compensatory response to loss of excitatory drive from the orexin neurons and may contribute to some of the symptoms of narcolepsy such as preserved consciousness during cataplexy and fragmented nighttime sleep. In addition, this finding may have therapeutic implications, as medications that enhance histamine signaling are now under development.
© 2013 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24006291     DOI: 10.1002/ana.24019

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  48 in total

1.  Effect of suvorexant on event-related oscillations and EEG sleep in rats exposed to chronic intermittent ethanol vapor and protracted withdrawal.

Authors:  Manuel Sanchez-Alavez; Jessica Benedict; Derek N Wills; Cindy L Ehlers
Journal:  Sleep       Date:  2019-04-01       Impact factor: 5.849

2.  Challenges in diagnosing narcolepsy without cataplexy: a consensus statement.

Authors:  Christian R Baumann; Emmanuel Mignot; Gert Jan Lammers; Sebastiaan Overeem; Isabelle Arnulf; David Rye; Yves Dauvilliers; Makoto Honda; Judith A Owens; Giuseppe Plazzi; Thomas E Scammell
Journal:  Sleep       Date:  2014-06-01       Impact factor: 5.849

3.  Normal Morning Melanin-Concentrating Hormone Levels and No Association with Rapid Eye Movement or Non-Rapid Eye Movement Sleep Parameters in Narcolepsy Type 1 and Type 2.

Authors:  Maren Schrölkamp; Poul J Jennum; Steen Gammeltoft; Anja Holm; Birgitte R Kornum; Stine Knudsen
Journal:  J Clin Sleep Med       Date:  2017-02-15       Impact factor: 4.062

Review 4.  Challenges in the development of therapeutics for narcolepsy.

Authors:  Sarah Wurts Black; Akihiro Yamanaka; Thomas S Kilduff
Journal:  Prog Neurobiol       Date:  2015-12-23       Impact factor: 11.685

5.  A Novel Developmental Role for Dopaminergic Signaling to Specify Hypothalamic Neurotransmitter Identity.

Authors:  Yu-Chia Chen; Svetlana Semenova; Stanislav Rozov; Maria Sundvik; Joshua L Bonkowsky; Pertti Panula
Journal:  J Biol Chem       Date:  2016-08-18       Impact factor: 5.157

6.  Hypocretin-1 Levels Associate with Fragmented Sleep in Patients with Narcolepsy Type 1.

Authors:  Anniina Alakuijala; Tomi Sarkanen; Markku Partinen
Journal:  Sleep       Date:  2016-05-01       Impact factor: 5.849

7.  Disrupted Sleep in Narcolepsy: Exploring the Integrity of Galanin Neurons in the Ventrolateral Preoptic Area.

Authors:  Yury V Gavrilov; Brian A Ellison; Mihoko Yamamoto; Hasini Reddy; Johannes Haybaeck; Emmanuel Mignot; Christian R Baumann; Thomas E Scammell; Philipp O Valko
Journal:  Sleep       Date:  2016-05-01       Impact factor: 5.849

8.  Conditional ablation of orexin/hypocretin neurons: a new mouse model for the study of narcolepsy and orexin system function.

Authors:  Sawako Tabuchi; Tomomi Tsunematsu; Sarah W Black; Makoto Tominaga; Megumi Maruyama; Kazuyo Takagi; Yasuhiko Minokoshi; Takeshi Sakurai; Thomas S Kilduff; Akihiro Yamanaka
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

Review 9.  Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders.

Authors:  Shi-Bin Li; Jeff R Jones; Luis de Lecea
Journal:  Curr Psychiatry Rep       Date:  2016-01       Impact factor: 5.285

10.  Damage to Arousal-Promoting Brainstem Neurons with Traumatic Brain Injury.

Authors:  Philipp O Valko; Yuri V Gavrilov; Mihoko Yamamoto; Daniela Noaín; Hasini Reddy; Johannes Haybaeck; Serge Weis; Christian R Baumann; Thomas E Scammell
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.